Calcilytics inhibit the proliferation and migration of human prostate cancer PC-3 cells
The carcinogenesis and development of prostate cancer are mediated by enhanced Ca2+ signaling. In the present study, the pharmacological profile of the Ca2+-sensing receptor (CaSR) antagonists (calcilytics) was examined in human prostate cancer PC-3 cells. NPS2143 and Calhex 231 blocked extracellula...
Main Authors: | Aya Yamamura, Md Junayed Nayeem, Motohiko Sato |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319300131 |
Similar Items
-
Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension.
by: Aya Yamamura, et al.
Published: (2015-01-01) -
MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3
by: Aya Yamamura, et al.
Published: (2021-04-01) -
Synthesis of the calcilytic ligand NPS 2143
by: Henrik Johansson, et al.
Published: (2013-07-01) -
MicroRNA-143 Inhibits Migration of Human Prostate Cancer Cells (PC3)
by: Elshan Bazhan, et al.
Published: (2017-07-01) -
The effects of hesperetin on apoptosis induction and inhibition of cell proliferation in the prostate cancer PC3 cells
by: Shirzad Moein, et al.
Published: (2015-10-01)